|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.994
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.991
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.989
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.987
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.983
|
Human Mouse |
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.980
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.973
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.965
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.964
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.961
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.960
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.952
|
Human |
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.943
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
14 |
0.940
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.937
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.932
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.926
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.912
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.912
|
Mouse |
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.908
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.903
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.899
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.895
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.880
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase activity
|
GO:0043553 |
1 |
0.878
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.851
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.848
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.847
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.846
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.839
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.833
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.833
|
Mouse |
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.829
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.825
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.821
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.812
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.810
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.807
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.807
|
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
17 |
0.805
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.804
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.804
|
Mouse |
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.803
|
Human |
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.802
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.800
|
Human |
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.797
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.790
|
|
|
|
positive regulation of cardiac muscle cell apoptotic process
|
GO:0010666 |
3 |
0.776
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.773
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.763
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.755
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.750
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.737
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.737
|
|
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.727
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.722
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.716
|
Human |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.712
|
Human |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.712
|
Mouse |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.710
|
Human |
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.703
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.695
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.691
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.683
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.683
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.682
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.679
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.671
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.666
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.663
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.657
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.654
|
Human |
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.653
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.650
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.648
|
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.647
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.641
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.641
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.640
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.639
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.634
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.633
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.630
|
|
|
|
mitochondrial dna repair
|
GO:0043504 |
3 |
0.628
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.626
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.620
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
4 |
0.614
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.614
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.612
|
|
|
|
apoptotic process involved in embryonic digit morphogenesis
|
GO:1902263 |
3 |
0.610
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.609
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.609
|
|
|
|
negative regulation of oxidative stress induced cell death
|
GO:1903202 |
9 |
0.604
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.603
|
Human |
|
|
regulation of somitogenesis
|
GO:0014807 |
6 |
0.600
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.597
|
Human |
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.596
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.595
|
Mouse |
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.589
|
Mouse |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.586
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.585
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.584
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.582
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.577
|
Human Mouse |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.576
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.573
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.572
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.571
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.568
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.568
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.565
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.564
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.563
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.557
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.557
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.554
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.553
|
|
|
|
positive regulation of striated muscle cell apoptotic process
|
GO:0010663 |
3 |
0.547
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.545
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.544
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.542
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.541
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.535
|
Human |
|
|
regulation of transcription from rna polymerase ii promoter in response to oxidative stress
|
GO:0043619 |
2 |
0.534
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.529
|
Human |
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.520
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.519
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.516
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.514
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.508
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.507
|
|
|
|
regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902108 |
14 |
0.499
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.499
|
|
|
|
negative regulation of lipid kinase activity
|
GO:0090219 |
1 |
0.496
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.495
|
Mouse |
|
|
ectopic germ cell programmed cell death
|
GO:0035234 |
9 |
0.495
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.494
|
Mouse |
|
|
kidney development
|
GO:0001822 |
213 |
0.493
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.483
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.481
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.481
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.480
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.480
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.479
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.475
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.473
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.473
|
Human |
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.471
|
|
|
|
positive regulation of p38mapk cascade
|
GO:1900745 |
1 |
0.470
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.469
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.469
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.466
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.460
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.460
|
|
|
|
positive regulation of cell cycle g1 s phase transition
|
GO:1902808 |
9 |
0.460
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.459
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.457
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.453
|
Human |
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.451
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.447
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.442
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.442
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.442
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.441
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.439
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.433
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.433
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.432
|
|
|
|
negative regulation of ubiquitin protein transferase activity
|
GO:0051444 |
3 |
0.428
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.428
|
|
|
|
regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902175 |
9 |
0.427
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.413
|
Human Mouse |
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.413
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.413
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.401
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.400
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.398
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.396
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.396
|
Mouse |
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.395
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
3 |
0.394
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.394
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.385
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.384
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.384
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.384
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.381
|
Human |
|
|
positive regulation of protein oligomerization
|
GO:0032461 |
4 |
0.378
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.372
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.370
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.369
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.367
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.366
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.363
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.359
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.358
|
Human |
|
|
developmental maturation
|
GO:0021700 |
193 |
0.358
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.357
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.356
|
|
|
|
epithelial cell differentiation involved in prostate gland development
|
GO:0060742 |
13 |
0.356
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.356
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.356
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.354
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.351
|
|
|
|
regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway
|
GO:1903376 |
3 |
0.348
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.348
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.346
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.346
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.343
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.343
|
|
|
|
positive regulation of mitochondrial membrane permeability
|
GO:0035794 |
12 |
0.340
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.339
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.339
|
|
|
|
negative regulation of syncytium formation by plasma membrane fusion
|
GO:0034242 |
5 |
0.336
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.335
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.333
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.329
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.326
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.324
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.324
|
|
|
|
negative regulation of cellular response to oxidative stress
|
GO:1900408 |
10 |
0.324
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.323
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.323
|
|
|
|
regulation of blood vessel remodeling
|
GO:0060312 |
3 |
0.322
|
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
10 |
0.320
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.315
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.313
|
|
|
|
centrosome organization
|
GO:0051297 |
26 |
0.311
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.307
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.306
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.304
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.304
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.304
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.303
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.301
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.300
|
Mouse |
|
|
negative regulation of cell cycle arrest
|
GO:0071157 |
1 |
0.300
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.295
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.295
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.294
|
Human |
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.289
|
|
|
|
negative regulation of interferon gamma mediated signaling pathway
|
GO:0060336 |
1 |
0.288
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.287
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.287
|
|
|
|
response to chromate
|
GO:0046687 |
1 |
0.285
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.285
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.282
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.282
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.281
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.280
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.279
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.279
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.278
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.278
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.276
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.276
|
Human |
|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
1 |
0.275
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.274
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.274
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.274
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.272
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.272
|
Human |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.272
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.272
|
|
|
|
mitotic cell cycle arrest
|
GO:0071850 |
4 |
0.272
|
|
|
|
response to lithium ion
|
GO:0010226 |
10 |
0.271
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.270
|
Human |
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.269
|
|
|
|
plasma membrane long chain fatty acid transport
|
GO:0015911 |
1 |
0.262
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.261
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.258
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.258
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.257
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.256
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.253
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.250
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.250
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.248
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.248
|
|
|
|
mitochondrion degradation
|
GO:0000422 |
3 |
0.247
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.244
|
|
|
|
regulation of epidermal cell division
|
GO:0010482 |
3 |
0.243
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.240
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.240
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.240
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.238
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.237
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.235
|
|
|
|
microtubule depolymerization
|
GO:0007019 |
15 |
0.234
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.232
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.230
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.229
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.226
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.226
|
Human |
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.225
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.225
|
|
|
|
regulation of mammary gland involution
|
GO:1903519 |
4 |
0.223
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.223
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.223
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902255 |
2 |
0.221
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.219
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.218
|
|
|
|
positive regulation of muscle cell apoptotic process
|
GO:0010661 |
6 |
0.218
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.216
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.216
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.215
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.215
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.210
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.210
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.210
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.210
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.210
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.209
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.208
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.207
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.206
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.205
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.205
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.204
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.204
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.204
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.204
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.203
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.202
|
Mouse |
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.202
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.202
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.201
|
|
|
|
positive regulation of protein acetylation
|
GO:1901985 |
9 |
0.201
|
|
|
|
regulation of anoikis
|
GO:2000209 |
2 |
0.200
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.199
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.198
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.198
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.196
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.194
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.194
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.194
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.194
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.193
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.193
|
|
|
|
regulation of endothelial cell chemotaxis
|
GO:2001026 |
1 |
0.192
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.192
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.191
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.191
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.191
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.190
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.190
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.190
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.189
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.188
|
Mouse |
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.188
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.188
|
Human |
|
|
limb development
|
GO:0060173 |
166 |
0.185
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.185
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.183
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.182
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.181
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.180
|
|
|
|
regulation of membrane permeability
|
GO:0090559 |
18 |
0.180
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.180
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.180
|
Mouse |
|
|
circulatory system process
|
GO:0003013 |
197 |
0.179
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.179
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.177
|
|
|
|
growth involved in heart morphogenesis
|
GO:0003241 |
4 |
0.176
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.176
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.175
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.175
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.174
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.174
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.174
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.173
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.172
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.172
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.171
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.170
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.167
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
24 |
0.166
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.166
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.165
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.165
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.165
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.164
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.164
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
4 |
0.163
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.163
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.162
|
|
|
|
glomerular capillary formation
|
GO:0072104 |
6 |
0.162
|
|
|
|
regulation of cellular response to hypoxia
|
GO:1900037 |
2 |
0.161
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.161
|
|
|
|
cgmp mediated signaling
|
GO:0019934 |
3 |
0.161
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.160
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.159
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.159
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
17 |
0.159
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.159
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.157
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.156
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.156
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.155
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.155
|
|
|
|
stress response to metal ion
|
GO:0097501 |
3 |
0.155
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.155
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.154
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.153
|
|
|
|
hypoxia inducible factor 1alpha signaling pathway
|
GO:0097411 |
2 |
0.152
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.151
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.151
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.151
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.151
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.151
|
|
|
|
traversing start control point of mitotic cell cycle
|
GO:0007089 |
2 |
0.150
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.150
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.149
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.146
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.146
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.145
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.145
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.145
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.144
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.144
|
|
|
|
renal system vasculature morphogenesis
|
GO:0061438 |
7 |
0.144
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.143
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.142
|
|
|
|
regulation of lipid kinase activity
|
GO:0043550 |
14 |
0.142
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.142
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.142
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.141
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.141
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.141
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.140
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.140
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.140
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.140
|
Human |
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.139
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.139
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.138
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.138
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.138
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.138
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.137
|
|
|
|
positive regulation of keratinocyte differentiation
|
GO:0045618 |
3 |
0.136
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.135
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.134
|
|
|
|
neutrophil apoptotic process
|
GO:0001781 |
3 |
0.134
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.134
|
Human |
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.133
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.133
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.132
|
|
|
|
b cell lineage commitment
|
GO:0002326 |
4 |
0.132
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.132
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.131
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.131
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.131
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.130
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.129
|
|
|
|
regulation of ubiquitin protein transferase activity
|
GO:0051438 |
7 |
0.128
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.128
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.127
|
|
|
|
signal transduction involved in mitotic g1 dna damage checkpoint
|
GO:0072431 |
3 |
0.127
|
Human |
|
|
oocyte development
|
GO:0048599 |
33 |
0.127
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.127
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.126
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.125
|
|
|
|
microtubule organizing center organization
|
GO:0031023 |
28 |
0.125
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.124
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.124
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.123
|
|
|
|
rrna transcription
|
GO:0009303 |
9 |
0.123
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.123
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.122
|
Mouse |
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.122
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.121
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.121
|
Human |
|
|
cloacal septation
|
GO:0060197 |
2 |
0.120
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.120
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.120
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
2 |
0.120
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.120
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.120
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.119
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.119
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.119
|
|